AFP and liver cancer: This study revealed significant associations between various factors, including ALBI grade, baseline AFP levels, early AFP response, ALP, γ-glutamyl, AST, and absolute counts of leukocytes and monocytes, with early tumor progression in liver cancer patients following ICI combined with targeted therapy.